HCV ADVOCATE WEEKLY NEWS REVIEW

[Guest guest]

HCV ADVOCATE WEEKLY NEWS REVIEW

This Issue:

Real-World Treatment Patterns, Non-Adherence, and Costs in Chronic Hepatitis C There Must Be a Place in the Guinness Book for Jette Paradigm Shift in Hepatitis C Testing May Curb the Numbers Affected, Says Expert Unequal Outcomes despite Equal Treatment Engineering a New Way to Study Hepatitis C Dynavax Reports Positive Phase 1b Data for SD-101 in Chronic Hepatitis C Infection 18 Hepatitis Cases to Be Settled Beyond the Ice: Technique for Preserving Pre-Transplant Livers Promises to Improve Patient Outcomes and Expand the Organ Pool Proposed Study for Liver Cancer Previewed at Interventional Oncology Meeting Don't Fatten Your Liver Health Tragedy: Patients Denied Life-Saving Transplants for Their "Abuse of Illicit Substances" NVHR Issues Challenge to Administration, Congress: Don't Leave 5 Million Americans Afflicted with Chronic Viral Hepatitis out in the Cold with Budget Freeze Tripep: Follow up of ChronVac-C®-Study with a 5th Dose Commenced Liver Transplants Do Not Impair Immune Response in HIV/HCV Coinfected Patients Race Team Promotes Hepatitis C Awareness Achillion Announces Nomination of ACH-2684 as Lead Clinical Candidate in Resistance-Focused HCV Program Barlow Bill Grows out of Kurt Beach's Experience Coffee Break Boosts Memory Conatus Pharmaceuticals Initiates Phase II Clinical Trial in Combination with Pegylated Interferon and Ribavirin for the Treatment of Hepatitis C Virus (HCV) Allegheny General Hospital Liver Transplant Program Certified Catholic Charities to Give Syringes to Drug Users Cancer in Remission, Now Comic Schimmel Needs a Liver Transplant

http://www.hcvadvocate.org/news/newsRev/2010/NewsRev-346.html